A study carried out in Brazil has shown that VEGF gene polymorphism may increase the potential for rapid tumor progression in people infected with hepatitis C. It has also been reported that patients diagnosed with hepatocellular cancers with polymorphisms are more likely to be diagnosed with multinodular disease and may have a negative impact on response to treatment19. The gene discussed is VEGFA; the disease is hepatitis C virus infection.